Skip to main content
SpringerLink
Log in

Testing for Breast Cancer Risk in the Ashkenazim

  • Chapter
Cancer Genetics for the Clinician

  • 78 Accesses

Abstract

Breast cancer is the most common gender-specific malignancy among women. In the United States, over 180,000 women are diagnosed with breast cancer each year, and 46,000 die of the disease.1,2 One out of eight, or 12.6%, of all women can expect to develop breast cancer at some time during her lifetime and for 1 in 30 women, breast cancer will be the cause of death.3 Although breast cancer may also affect men, the frequency among males is quite small, approximately 1% of the total number of breast cancers.1

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Cancer Society: Cancer facts and figures:1995. Atlanta, GA, 1995

    Google Scholar 

  2. Wingo PA, Landis S, Ries LA: An adjustment to the 1997 estimate for new prostate cancer cases. Cancer 80:1810–1813, 1810

    Article  Google Scholar 

  3. Ries L, Miller B, Hankey T, et al: Cancer statistics review 1973-91: tables and graphs. Bethesda, MD, 1994

    Google Scholar 

  4. Struewing JP, Abeliovich D, Peretz T, et al: The carrier frequency of the BRCA1185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals Nature Genet 11:198–200, 1995

    Article  PubMed  CAS  Google Scholar 

  5. Newman B, Austin MA, Lee M, et al: Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proceed Natl Acad of Sci USA 85:3044–3048, 1988

    Article  CAS  Google Scholar 

  6. Egan K, Newcomb P, Longnecker M, et al: Jewish religion and risk of breast cancer. Lancet 347:1638–1639, 1996

    Article  Google Scholar 

  7. Hall JM, Lee MK, Newman B, et al: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684–1689, 1990

    Article  PubMed  CAS  Google Scholar 

  8. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71, 1994

    Article  PubMed  CAS  Google Scholar 

  9. Wooster R, Neuhausen SL, Mangion J, et al: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13ql2-13. Science 265:2088–2090, 1994

    Article  PubMed  CAS  Google Scholar 

  10. Wooster R, Bignell G, Lancaster J, et al: Identification of the breast cancer susceptibility gene BRCA2 Nature 378:789–792, 1995

    Article  PubMed  CAS  Google Scholar 

  11. Couch F, Farid L, DeShano M, et al: BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nature Genet 13:123–125, 1996

    Article  PubMed  CAS  Google Scholar 

  12. Vehmanen P, Friedman LS, Eerola H, et al: A low proportion of BRCA2 mutations in Finnish breast cancer families. Am J Hum Genet 60:1050–1058, 1997

    PubMed  CAS  Google Scholar 

  13. Krainer M, Silva-Arrieta S, FitzGerald MG, et al: Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. New Engl J Med 336:1416–1421, 1997

    Article  PubMed  CAS  Google Scholar 

  14. Struewing JP, Hartge P, Wacholder S, et al: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New Engl J Med 336:1401–1408, 1997

    Article  PubMed  CAS  Google Scholar 

  15. Tonin P, Weber B, Offit K, et al: Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nature Med 2:1179–1183, 1996

    Article  PubMed  CAS  Google Scholar 

  16. Schubert EL, Lee MK, Mefford HC, et al: BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am J of Hum Genet 60:1031–1040, 1997

    CAS  Google Scholar 

  17. Thorlacius S, Sigurdsson S, Bjamadottir H, et al: Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J of Hu Genet 60:1079–1084, 1997

    CAS  Google Scholar 

  18. Narod SA, Ford D, Devilee P, et al: An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J of Hum Genet 56:254–264, 1995

    CAS  Google Scholar 

  19. Couch F, DeShano M, Blackwood M, et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. New Engl J Med 336, 1996

    Google Scholar 

  20. Li FP, Fraumeni JF, Jr: Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Annals of Internal Med 71:747–52, 1969

    CAS  Google Scholar 

  21. Swift M, Morrell D, Massey RB, et al: Incidence of cancer in 161 families affected by ataxia-telangiectasia. New Engl J Med 325:1831–6, 1831

    Article  Google Scholar 

  22. Easton D: Cancer risks in A-T heterozygotes. Int J Radiat Biol 66:S177–S182, 1994

    Article  PubMed  CAS  Google Scholar 

  23. Bishop DT, Hopper J: AT-tributable risks? Nature Genet 15, 1997

    Google Scholar 

  24. Wooster R, Mangion J, Eeles R, et al: A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genet 2:132–134, 1992

    Article  PubMed  CAS  Google Scholar 

  25. Phelan CM, Rebbeck TR, Weber BL, et al: Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nature Genet 12:309–311, 1996

    Article  PubMed  CAS  Google Scholar 

  26. Couch F, Weber B, and the Breast Cancer Information Core: Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum Mut 8:8–18, 1996

    Article  PubMed  CAS  Google Scholar 

  27. Stratton MR: Recent advances in understanding of genetic susceptibility to breast cancer. Hum Mol Genet 1515-1519, 1996

    Google Scholar 

  28. Shattuck-Eidens D, McClure M, Simard J, et al: A collaborative study of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility genes. Implications for presymptomatic testing and screening. JAMA 273:535–541, 1995

    Article  PubMed  CAS  Google Scholar 

  29. Gayther SA, Mangion J, Russell P, et al: Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nature Genet 15:103–105, 1997

    Article  PubMed  CAS  Google Scholar 

  30. Hakansson S, Johansson O, Johansson U, et al: Moderate frequency of BRCA1 and BRCA2 germline mutations in Scandinavian breast cancer families. Am J Hum Genet 60:1068–1078, 1997

    PubMed  CAS  Google Scholar 

  31. Peelen T, van VM, Petrij-Bosch A, et al: A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families [see comments]. American Journal of Human Genet 60:1041–1049, 1997

    CAS  Google Scholar 

  32. Serova O, Montagna M, Torchard D, et al: A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J of Hum Genet 58:42–51, 1996

    CAS  Google Scholar 

  33. Gao Q, Neuhausen S, Cummings S, et al: Recurrent germline BRCA1 mutatuions in extended African American families with early onset breast cancer. Am J Hum Genet 60:428–433, 1997

    Google Scholar 

  34. Easton DF, Ford D, Bishop DT: Breast and ovarian cancer incidence in BRCA1-mutation carriers. American Journal of Human Genet 56:265–271, 1995

    CAS  Google Scholar 

  35. FitzGerald MG, MacDonald DJ, Krainer M, et al: Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. New Engl J of Med 334:143–149, 1996

    Article  CAS  Google Scholar 

  36. Langston A, Malone K, Thompson J, et al: BRCA1 mutations in a population-based sample of young women with breast cancer. New Engl J Med 334:137–142, 1996

    Article  PubMed  CAS  Google Scholar 

  37. Oddoux C, Struewing JP, Clayton CM, et al: The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nature Genet 14:188–190, 1996

    Article  PubMed  CAS  Google Scholar 

  38. Roa B, Boyd A, Volcik K, et al: Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genet 14:185–187, 1996

    Article  PubMed  CAS  Google Scholar 

  39. Neuhausen S, Gilewski T, Norton L, et al: Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected with breast cancer. Nature Genet 13:126–128, 1996

    Article  PubMed  CAS  Google Scholar 

  40. Friedman LS, Szabo CI, Ostermeyer EA, et al: Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J of Hum Genet 57:1284–1297, 1995

    CAS  Google Scholar 

  41. Gayther S, Harrington P, Russell P, et al: Frequently occuring germline mutations of the BRCA1 gene in ovarian cancer families from Russia. Am J Hum Genet 60:1239–1242, 1997

    PubMed  CAS  Google Scholar 

  42. Ford D, Easton DF, Bishop DT, et al: Risks of cancer in BRCAl-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343:692–695, 1994

    Article  PubMed  CAS  Google Scholar 

  43. Tonin P, Ghadirian P, Phelan C, et al: A large multisite cancer family is linked to BRCA2. J of Med Genet 32:982–984, 1995

    Article  CAS  Google Scholar 

  44. Hoskins KF, Stopfer JE, Calzone KA, et al: Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA 273:577–585, 1995

    Article  PubMed  CAS  Google Scholar 

  45. Anderson D, Badzioch M: Risk of familial breast cancer. Cancer 56:383–387, 1985

    Article  PubMed  CAS  Google Scholar 

  46. Gail MH, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879–1886, 1879

    Article  Google Scholar 

  47. Claus EB, Risch N, Thompson WD: Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73:643–51, 1994

    Article  PubMed  CAS  Google Scholar 

  48. Colditz GA, Willett WC, Hunter DJ, et al: Family history, age, and risk of breast cancer. Prospective data from the Nurses’ Health Study [published erratum appears in JAMA 1993 Oct 6;270(13):1548]. JAMA 270:338–343, 1993

    Article  PubMed  CAS  Google Scholar 

  49. Laken SJ, Petersen GM, Gruber SB, et al: Familial colorectal cancer in Ashkenazim due to a hyper-mutable tract in APC. Nature Genet 17:79–83, 1997

    Article  PubMed  CAS  Google Scholar 

  50. Burke W, Daly M, Garber J, et al: Recommendations for follow-up care of individuals with an inherited predisposition to cancer II. BRCA1 and BRCA2. JAMA 277:997–1003, 1997

    Article  PubMed  CAS  Google Scholar 

  51. Anonymous: Reports of the working group to review the National Cancer Institute—American Cancer Society breast cancer detection project. J Natl Cancer Inst 62:639–709, 1979

    Google Scholar 

  52. Greenwald P, Nasca P, Lawrence C, et al: Estimated effect of breast self examination and routine physician examinations on breast cancer mortality. New Engl J Med 299:271–273, 1978

    Article  PubMed  CAS  Google Scholar 

  53. Kerlikowske K, Grady D, Rubin S, et al: Efficacy of screening mammography: a meta-analysis. JAMA 273:149–154, 1995

    Article  PubMed  CAS  Google Scholar 

  54. Fletcher S, Black W, Harris R, et al: Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 85:1644–1656, 1995

    Article  Google Scholar 

  55. Mettler F, Upton A, Kelsey C, et al: Benefits versus risks from mammography. Cancer 77:903–909, 1996

    Article  PubMed  CAS  Google Scholar 

  56. van Nagell J, Higgins R, Donaldson E, et al: Transvaginal sonography as a screening method for ovarian cancer. Cancer 65:573–577, 1990

    Article  PubMed  Google Scholar 

  57. Daly M: The epidemiology of ovarian cancer. Hematol Oncol Clin N Amer 6:729–738, 1992

    CAS  Google Scholar 

  58. Kurjak A, Zalud I, Alfirevic Z: Examination of adnexal masses with transvaginal color ultrasound. J Ultrasound Med 10:295–297, 1991

    PubMed  CAS  Google Scholar 

  59. Jacobs I, Bast R, Jr: The CA-125 tumor-associated antigen. Hum Reprod 4:1–12, 1989

    Article  PubMed  CAS  Google Scholar 

  60. Skates S, Feng-Ji X, Yin-Hua Y, et al: Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer 76:2004–2010, 1995

    Article  PubMed  CAS  Google Scholar 

  61. US Preventive Services Task Force: Guide to Clinical Preventive Services. Baltimore, 1996

    Google Scholar 

  62. Mettlin C, Jones G, Averette H, et al: Defining and updating the American Cancer Society Guidelines for cancer-related check-up. Cancer J Clin 43, 1993

    Google Scholar 

  63. Levin B, Murphy G: Revision in American Cancer Society recommendations for the early detection of colorectal cancer. Cancer J clin 42:296–299, 1992

    Article  CAS  Google Scholar 

  64. Selby J, Freedman G, Queensberry C, Jr., et al: A case-control study of screening sigmoidoscopy and mortality from coorectal cancer. New Engl J Med 326:653–657, 1992

    Article  PubMed  CAS  Google Scholar 

  65. Cancer NCPoO: Ovarian cancer screening, treatment, and follow-up. JAMA 273:491–497, 1995

    Article  Google Scholar 

  66. Schrag D, Kuntz K, Garber J, et al: Decision analysis—Effects of prophylactic mastectomy and oophrectomy on ife expectancy among women with BRCA1 and BRCA2 mutations. New Engl J Med 336:1465–1471, 1997

    Article  PubMed  CAS  Google Scholar 

  67. Billimoria M, Morrow M: The woman at increased risk for breast cancer: evaluation and management strategies. Cancer J Clin 45:263–278, 1995

    Article  Google Scholar 

  68. Tobachman J, Tucker M, Kase R: Intraabdominal carcinomatosis after prophylatic oophrectomy in ovarian cancer prone families. Lancet 2:795–797, 1982

    Article  Google Scholar 

  69. Piver M, Jishi M, Tsukada Y, et al: Primary peritoneal carcinoma after prophylactic oophrectomy in women with a family history of ovarian cancer. Cancer 71, 1993

    Google Scholar 

  70. Struewing JP, Watson P, Easton DF, et al: Prophylactic oophorectomy in inherited breast/ovarian cancer families. Journal of the National Cancer Institute. Monographs 17:33–35, 1995

    PubMed  Google Scholar 

  71. Colditz G, Hankinson S, Hunter D, et al: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl J Med 332:1589–1593, 1995

    Article  PubMed  CAS  Google Scholar 

  72. Cancer CGoHFiB: Breast cancer and hormonal contraceptives. Lancet 347, 1996

    Google Scholar 

  73. Gradym D, Rubin S, Petitti D, et al: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Int Med 117, 1992

    Google Scholar 

  74. Col N, Eckman M, Karas R, et al: Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA 277, 1997

    Google Scholar 

  75. Ostrer H, Allen W, Crandall L, et al: Insurance and genetic testing: Where are we now? Am J Hum Genet 52, 1993

    Google Scholar 

  76. Rothenberg K, Fuller B, Rothstein M, et al: Genetic information and the workplace: legislative approaches and policy changes. Science 275, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, NYU Medical Center Human Genetics Program, 550 First Avenue, New York, NY, 10016, USA

    Carole Oddoux, Elsa Reich & Harry Ostrer

Authors
  1. Carole Oddoux
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elsa Reich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Harry Ostrer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carole Oddoux .

Editor information

Editors and Affiliations

  1. H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, Florida, USA

    Gail L. Shaw

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Oddoux, C., Reich, E., Ostrer, H. (1999). Testing for Breast Cancer Risk in the Ashkenazim. In: Shaw, G.L. (eds) Cancer Genetics for the Clinician. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4699-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4699-3_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7128-1

  • Online ISBN: 978-1-4615-4699-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation